v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 10,647 $ 12,226
Accounts receivable 30  
Research and development tax credit receivable 1,324 1,070
Prepaid expenses and other current assets 1,265 802
Total current assets 13,266 14,098
Property, plant equipment, net of accumulated depreciation of $1,130 and $1,102 770 802
Right-of-use assets, net 90 154
Other assets 6 6
Total assets 14,132 15,060
LIABILITIES AND STOCKHOLDERS' EQUITY    
Accounts payable and accrued expenses 1,160 1,423
Current lease liabilities 56 87
Total current liabilities 1,216 1,510
Non-current lease liabilities 19 28
Total liabilities 1,235 1,538
Commitments and contingencies (Note 8)
Stockholders' Equity:    
Common stock, par value $0.0001 per share, 300,000,000 shares authorized, 26,566,809 and 25,554,309 shares issued and outstanding, at March 31, 2022 and December 31, 2021, respectively* 3 3
Additional paid-in capital 91,935 89,954
Accumulated other comprehensive loss (1,207) (1,363)
Accumulated deficit (77,834) (75,072)
Total Stockholders' equity 12,897 13,522
Total Liabilities and Stockholders' Equity $ 14,132 $ 15,060

Source